Edwards Lifesciences Corporation Acquisitions, Net of Cash Acquired
Edwards Lifesciences Corporation (EW) reported Acquisitions, Net of Cash Acquired of $100.20 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2020-02-14
- Edwards Lifesciences Corporation payments to acquire businesses, net of cash acquired for the quarter ending 2019-12-31 was $0.00.
- Edwards Lifesciences Corporation payments to acquire businesses, net of cash acquired for the quarter ending 2019-09-30 was $0.00.
- Edwards Lifesciences Corporation payments to acquire businesses, net of cash acquired for the quarter ending 2019-06-30 was $65.20M.
- Edwards Lifesciences Corporation payments to acquire businesses, net of cash acquired for the quarter ending 2019-03-31 was $35.00M.
- Edwards Lifesciences Corporation payments to acquire businesses, net of cash acquired for fiscal 2019 was $100.20M.
- Edwards Lifesciences Corporation payments to acquire businesses, net of cash acquired for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Edwards Lifesciences Corporation payments to acquire businesses, net of cash acquired for fiscal 2017 was $192.90M.
- Edwards Lifesciences Corporation payments to acquire businesses, net of cash acquired for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $0.00 derived: sum of 2 quarters · filed 2020-02-14 | $65.20M derived: sum of 3 quarters · filed 2020-02-14 | $100.20M 10-K · filed 2020-02-14 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $65.20M derived: sum of 2 quarters · filed 2019-10-25 | $100.20M 10-Q · filed 2019-10-25 | $100.20M derived: sum of 4 quarters · filed 2020-02-14 |
| 2019-06-30 | $65.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $100.20M 10-Q · filed 2019-07-26 | $100.20M derived: sum of 3 quarters · filed 2020-02-14 | $100.20M derived: sum of 4 quarters · filed 2020-02-14 |
| 2019-03-31 | $35.00M 10-Q · filed 2019-04-26 | $35.00M derived: sum of 2 quarters · filed 2020-02-14 | $35.00M derived: sum of 3 quarters · filed 2020-02-14 | $35.00M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $0.00 derived: sum of 2 quarters · filed 2020-02-14 | $0.00 derived: sum of 3 quarters · filed 2020-02-14 | $0.00 10-K · filed 2020-02-14 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $0.00 derived: sum of 2 quarters · filed 2019-10-25 | $0.00 10-Q · filed 2019-10-25 | $108.00M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $0.00 10-Q · filed 2019-07-26 | $108.00M derived: sum of 3 quarters · filed 2020-02-14 | $108.10M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $0.00 10-Q · filed 2019-04-26 | $108.00M derived: sum of 2 quarters · filed 2020-02-14 | $108.10M derived: sum of 3 quarters · filed 2020-02-14 | $110.90M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $108.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $108.10M derived: sum of 2 quarters · filed 2020-02-14 | $110.90M derived: sum of 3 quarters · filed 2020-02-14 | $192.90M 10-K · filed 2020-02-14 |
| 2017-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $2.90M derived: sum of 2 quarters · filed 2018-10-26 | $84.90M 10-Q · filed 2018-10-26 | $84.90M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $84.80M 10-Q · filed 2018-07-27 | $84.80M derived: sum of 3 quarters · filed 2019-02-15 | $84.80M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $82.00M 10-Q · filed 2018-04-27 | $82.00M derived: sum of 2 quarters · filed 2019-02-15 | $82.00M derived: sum of 3 quarters · filed 2019-02-15 | $82.00M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $0.00 derived: sum of 2 quarters · filed 2019-02-15 | $0.00 derived: sum of 3 quarters · filed 2019-02-15 | $0.00 10-K · filed 2019-02-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $0.00 derived: sum of 2 quarters · filed 2017-10-27 | $0.00 10-Q · filed 2017-10-27 | $11.50M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $0.00 10-Q · filed 2017-07-28 | $11.50M derived: sum of 3 quarters · filed 2018-02-16 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-04-28 | $11.50M derived: sum of 2 quarters · filed 2018-02-16 | ||
| 2015-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $331.60M 10-K · filed 2018-02-16 | ||
| 2015-09-30 | $320.10M 10-Q · filed 2016-10-28 | |||
| 2014-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $15.00M 10-K · filed 2017-02-17 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-10-29 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-19 | |||
| 2012-12-31 | $36.60M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $0.00 derived: sum of 3 quarters · filed 2014-02-28 | $42.60M 10-K · filed 2014-02-28 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $0.00 derived: sum of 2 quarters · filed 2012-11-07 | $42.60M 10-Q · filed 2012-11-07 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $42.60M 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $42.60M 10-Q · filed 2012-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |